

Product Brochure
Alpha Ketoanalogues and Essential Amino Acids Tablets For Nutrition To Chronic Kidney Failure
₹ 3,950/Box
| Packaging Size | 10*10 Tablets |
| Packaging Type | Strip |
| Shelf Life | 24 Months |
| Usage | treatment of chronic kidney disease |
| Prescription/Non Prescription | Non Prescription |
| Also gives | Pharmaceutical Third Party Manufacturing |
| Country of Origin | Made in India |
| Availability | In Stock |
| View in Hindi | अल्फा केटोएनालॉग और आवश्यक अमीनो अम्ल टैबलेट्स क्रोनिक किडनी विफलता के लिए पोषण |
Exports To: United States Of America | Germany | Italy | Saudi Arabia | Canada
Find related categories
Shipping Information
| Price | Excluding all taxes |
| Ships from | Mumbai |
| Shipping | As per delivery location |
Product Image



About the Company
- GST Registration Date
- Feb 2023
- Legal Status of Firm
- Limited Company
- Nature of Business
- Trader - Wholesaler/Distributor
- Number of Employees
- 11 To 25 People
- Annual Turnover
- 40 L - 1.5 Cr
- IndiaMART Member Since
- Mar 2023
- GST
- 27**********1ZK
- Import Export Code (IEC)
- *******16B
- Exports to
- United States Of America | Germany | Italy | Saudi Arabia | Canada
Established in the year of 2016, We “Narix Pharmaceuticals Private Limited” are Wholesaler Exporter, Distributor, Importer and Supplier of an Pharmaceutical Tablets, Oral Jelly, Pharmaceutical Capsules, Pharmaceutical Soap, Pharmaceutical Cream, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to our Mr. Naman, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
For our accomplishment story, we are grateful to our Mr. Naman, whose continual backing and direction have been useful to us for attaining exponential development in the current market.









